790705-08-7

Basic information

• Product Name: tert-butyl 4-Methylideneazepane-1-carboxylate
• Synonyms: tert-butyl 4-Methylideneazepane-1-carboxylate;tert-Butyl4-Methyleneazepane-1-carboxylate;4-Methyleneazepane-1-carboxylic acid tert-butyl ester
• CAS NO: 790705-08-7
• Molecular Formula: C₁₂H₂₁NO₂
• Molecular Weight: 211.30064
• Mol File: 790705-08-7.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: tert-butyl 4-Methylideneazepane-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-Methylideneazepane-1-carboxylate(790705-08-7)
• EPA Substance Registry System: tert-butyl 4-Methylideneazepane-1-carboxylate(790705-08-7)

Safety Data

• Hazardous Substances Data: 790705-08-7(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
Tert-butyl 4-Methylideneazepane-1-carboxylate is used as a reagent for the preparation of various organic molecules, particularly in the formation of cyclic structures. Its steric hindrance provided by the tert-butyl group influences the reactivity and selectivity of chemical reactions, making it a valuable building block in the creation of diverse chemical compounds.
Used in Pharmaceutical Research:
Tert-butyl 4-Methylideneazepane-1-carboxylate is used as a key intermediate in the development of new pharmaceutical drugs and materials. Its unique properties and reactivity make it a promising candidate for the synthesis of novel therapeutic agents and drug delivery systems.

Upstream product

• 188975-88-4 tert-butyl 4-oxoazepane-1-carboxylate 
• 2065-66-9 methyl-triphenylphosphonium iodide 
• 1779-49-3 Methyltriphenylphosphonium bromide 

Relevant articles and documents

Site-Specific Alkene Hydromethylation via Protonolysis of Titanacyclobutanes

Methyl groups are ubiquitous in biologically active molecules. Thus, new tactics to introduce this alkyl fragment into polyfunctional structures are of significant interest. With this goal in mind, a direct method for the Markovnikov hydromethylation of alkenes is reported. This method exploits the degenerate metathesis reaction between the titanium methylidene unveiled from Cp2Ti(μ-Cl)(μ-CH2)AlMe2 (Tebbe's reagent) and unactivated alkenes. Protonolysis of the resulting titanacyclobutanes in situ effects hydromethylation in a chemo-, regio-, and site-selective manner. The broad utility of this method is demonstrated across a series of mono- and di-substituted alkenes containing pendant alcohols, ethers, amides, carbamates, and basic amines.

INHIBITORS OF ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) AND METHODS OF USE THEREOF

Compounds and methods for their preparation and use as therapeutic or prophylactic agents, for example for treatment of cancer, bacterial or viral diseases by targeting Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1).

Oxazolidinone-quinolone hybrid antibiotics

The present invention relates to compounds of the Formula (I) that are useful antimicrobial agents and effective against a variety of multi-drug resistant bacteria:

Synthesis of functionalized 2-isoxazolines as three-dimensional fragments for fragment-based drug discovery

Abstract The design of new sp3 and spiro-enriched fragments has been achieved from 1,3-dipolar cycloaddition between alkenes and chloro-oximes. The selection of reagents was performed to afford a panel of 2-isoxazoline-containing fragments that show desirable three dimensional (3D) characteristics to allow the probing of biologically-relevant chemical space. Principal moments of inertia (PMI) were calculated to evaluate the 3D diversity. The resulting 3D fragments with suitable physicochemical properties, especially a good solubility, will be used to improve the hit rate of our fragment-based screening.

NOVEL KINASE INHIBITORS

The present invention provides derivatives of thiazolylamino-substituted heterocycles. These compounds are inhibitors of kinases, including compounds that show antiproliferative activity against cells, including against tumor cells, and are useful in the treatment of diseases including cancer.

7-(Piperazine-1-Ymethyl)-1H-Indole-2-Carboxylic Acid (Phenyl)-Amide Derivatives and Allied Compounds as P38 Map Kinase Inhibitors for the Treatment of Respiratory Diseases

The present invention provides compounds according to general formula (I) which are proposed for the treatment of respiratory complaints, particularly asthma and COPD.